Xenon Pharmaceuticals XENE Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's other operating expenses?
- Xenon Pharmaceuticals (XENE) reported other operating expenses of $112.33M in Q1 2026.
- How has Xenon Pharmaceuticals's other operating expenses changed year-over-year?
- Xenon Pharmaceuticals's other operating expenses increased by 40.0% year-over-year, from $80.24M to $112.33M.
- What is the long-term trend for Xenon Pharmaceuticals's other operating expenses?
- Over 4 years (2021 to 2025), Xenon Pharmaceuticals's other operating expenses has grown at a 40.6% compound annual growth rate (CAGR), from $97.43M to $380.57M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.